USPTO Allows Claims in Regulus Patent Application on miR-21

According to the company, the miRNA is linked to a variety of diseases including cancer, fibrosis, and heart disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.